Prosecution Insights
Last updated: August 17, 2026

Examiner: KOSTURKO, GEORGE W

Tech Center 1600 • Art Units: 1621 1627 1628

This examiner grants 55% of resolved cases

Performance Statistics

54.7%
Allow Rate
-5.3% vs TC avg
760
Total Applications
+48.6%
Interview Lift
988
Avg Prosecution Days
Based on 722 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
15.1%
§102 Novelty
40.8%
§103 Obviousness
24.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18271102 METHODS FOR PREVENTING OR TREATING CONDITIONS RELATED TO T CELL MEDIATED INTESTINAL DISORDERS Non-Final OA The Regents of the University of Michigan
18727727 GLYCOL COMPOSITIONS INCLUDING TOCOPHEROLS Non-Final OA Dow Global Technologies LLC
17187880 Early Stage Detection for Alzheimers and other Autoimmune Diseases Final Rejection VOC HEALTH, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month